Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Financial Position

v3.22.2
Condensed Consolidated Statements of Financial Position - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current:    
Cash and cash equivalents $ 19,025 $ 37,226
Restricted cash 438 473
Accounts receivable, net 3,391 2,222
Prepaids, deposits and other receivables 4,671 5,064
Inventories, net 16,740 15,408
Total current assets 44,265 60,393
Investment – Cansativa 5,747 1,458
Property, plant and equipment, net of accumulated depreciation of $7,159 and $5,702 for June 30, 2022 and December 31, 2021, respectively 29,502 30,932
Intangible assets, net 22,735 23,117
Operating lease right-of-use assets, net 3,210 0
Other non-current assets 3 260
Total Assets 105,462 116,160
Current:    
Accounts payable 3,225 3,981
Accrued expenses and other current liabilities 2,730 2,898
Convertible note due 2024, current portion 0 16,559
Loans and borrowings, current portion 526 949
Warrant liability 392 2,205
Operating lease liabilities, current portion 1,506 0
Deferred revenue, current portion 265 653
Total current liabilities 8,644 27,245
Convertible note due 2024 — long-term 0 1,140
Loans and borrowing — long-term 1,609 6,447
Deferred revenue 1,271 1,548
Operating lease liabilities — long-term 1,859 0
Deferred tax liabilities 6,650 6,650
Other long-term liabilities 840 360
Total Liabilities 20,873 43,390
Shareholders’ equity    
Common shares, without par value, unlimited shares authorized: 39,599,409 and 26,605,797 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively 0 0
Preferred shares, without par value, unlimited shares authorized, nil shares issued and outstanding for each of June 30, 2022 and December 31, 2021 0 0
Additional paid-in capital 216,515 187,510
Accumulated deficit (131,926) (114,740)
Total shareholders' equity 84,589 72,770
Total liabilities and shareholders' equity $ 105,462 $ 116,160